Oxybutynin Chloride Tablet
Product Images NDC 42291-456

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Oxybutynin Chloride (NDC 42291-456). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

500 (456 50)

FDA Label Image

This Is An Image Of The Structural Formula For Oxybutynin Chloride. (Ba6a2e1f 9d72 4814 820e C0b0d2305d10 01)

FDA Label Image

Figure 1. Mean R-oxybutynin Plasma Concentrations Following Three Doses Of Oxybutynin Chloride 5 mg Administered Every 8 Hours For 1 Day In 23 Healthy Adult Volunteers (Ba6a2e1f 9d72 4814 820e C0b0d2305d10 02)

Figure 1. Mean R-oxybutynin Plasma Concentrations Following Three Doses Of Oxybutynin Chloride 5 mg Administered Every 8 Hours For 1 Day In 23 Healthy Adult Volunteers (Ba6a2e1f 9d72 4814 820e C0b0d2305d10 02)
Mean Plasma R-Oxybutynin Concentration (ng/mL) at different time points (12 hours, 16 hours, 20 hours) after taking Oxybutynin 5 mg three times a day.*
FDA Label Image

Oxy 3 (Ba6a2e1f 9d72 4814 820e C0b0d2305d10 03)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.